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The aimwas to test for evidence of transcriptional activity within the nuclei of the syncytiotrophoblast of
the human placenta. The syncytiotrophoblast forms the epithelial covering of the villous tree, and is
a multinucleated, terminally-differentiated syncytium generated through fusion of the underlying
progenitor cytotrophoblast cells. Its nuclei are heterogeneous with respect to chromatin condensation,
and previous functional studies of 3H-uridine uptake in vitro have indicated that they are transcrip-
tionally inactive. This observation is surprising given the key roles this tissue plays in active transport,
hormone synthesis and metabolic regulation, and has widespread implications for trophoblast physi-
ology and pathophysiology. We used three different approaches to look for evidence of transcriptional
activity. First, immunoﬂuorescence staining was performed on parafﬁn-embedded early pregnancy and
term placental villi, using an antibody directed speciﬁcally against the actively transcribing form of RNA
polymerase II. Second, a nucleoside incorporation assay was applied to placental villi maintained in
short-term culture, with and without the transcription blocker a-amanitin. Third, histone modiﬁcations
associated with active chromatin were identiﬁed by immunohistochemistry and immunoﬂuorescence.
Each of these methods showed transcription to be occurring in a proportion of syncytiotrophoblast
nuclei, with qualitative evidence for transcription being more abundant in the ﬁrst trimester than at
term. These ﬁndings correlated with electron microscopical observations of prominent nucleoli within
the nuclei, particularly during early pregnancy, signifying transcription of ribosomal RNA. Contrary to
previous ﬁndings, these results conﬁrm that a proportion of syncytiotrophoblast nuclei actively produce
mRNA transcripts.
 2009 Elsevier Ltd. Open access under CC BY license.1. Introduction
Trophoblast forms the epithelial covering of the human
placental villous tree, and is the interface with the maternal blood.
Villous trophoblast consists of two cell populations, the cyto-
trophoblast (CTB) cells and the syncytiotrophoblast (STB). The STB
is a unique tissue, for it is an extensive terminally-differentiated
multinucleated syncytium with a surface area of approximately
12 m2 at term. Mitotic ﬁgures have never been observed within the
STB, but instead it is generated through proliferation, differentia-
tion and subsequent fusion of CTB cells [1]. Nuclei within the STB
will therefore be of different ages depending on the time of their
incorporation, and this may explain the range in theirst Research, University of
. Tel.: þ44 (0)1223 333856;
Y license.morphological appearances [2]. Whilst some nuclei display an open
euchromatic pattern, often with a prominent nucleolus, others
consist almost entirely of dense heterochromatin. The latter are
considered to be aged, effete nuclei, and are usually sequestered
together to form aggregates referred to as syncytial knots [3]. These
are rarely seen in normal placentas prior to 32 weeks of pregnancy,
becomemore frequent towards term, and are a conspicuous feature
of the post-mature placenta [4]. In pathological placentas there is
a modest increase in syncytial knots associated with preeclampsia,
but they are more strongly associated with disorders of fetal
perfusion of the villous tree, such as stem artery thrombosis [4].
Because of these differences in chromatin condensation it might
be expected that STB nuclei show a range of transcriptional activity.
However, results from a functional assay involving the incubation
of both ﬁrst trimester and term placental villi with a radiolabelled
nucleoside, 3H-uridine, revealed no incorporation into the STB
nuclei, suggesting a global suppression of transcriptional activity
[5,6]. The authors concluded that there is a continual need for CTB
P.M. Ellery et al. / Placenta 30 (2009) 329–334330fusion to bring fresh transcripts into the STB, and proposed a transit
of nuclei through the STB based around apoptosis [7,8]. This lack of
transcription is surprising, given the high secretory and metabolic
activities of the STB. It would also appear to hamper the respon-
siveness of the tissue to sudden changes in the intrauterine envi-
ronment, for the requirement for cell fusion to introduce more, or
different, transcripts must introduce an inevitable delay.
We therefore tested for evidence of transcriptional activity in
the STB nuclei at various gestational ages using three different
techniques. Firstly, immunoﬂuorescent staining for the actively
transcribing form of RNA polymerase II was performed on both
early pregnancy and term placental samples. Secondly, a nucleoside
incorporation assay using ﬂuorouridine was performed on
placental explants maintained under physiological conditions in
vitro. Thirdly, immunohistochemistry was performed for histone
methylation patterns associated with active transcription. In addi-
tion, transmission electron microscopy was performed to examine
nuclear morphology.
2. Materials and methods
2.1. Sample collection and tissue processing
Tissue collection was approved by the relevant local research ethics committees
in Cambridge and London. Human placentas were obtained, with informed consent,
from normal, uncomplicated pregnancies undergoing either surgical termination at
5–17 weeks gestational age or elective caesarean delivery at term. Samples were
ﬁxed in 4% paraformaldehyde (PFA) overnight at 4 C for immunohistochemistry, or
in 2% glutaraldehyde for 2 h for electron microscopy.
2.2. Immunoﬂuorescence and immunohistochemistry
For immunoﬂuorescence, PFA-ﬁxed tissues were embedded in parafﬁn wax,
sectioned at 7 mm, and dewaxed. Antigen retrieval was then performed using
0.02 mg/ml proteinase K (Sigma, Poole, UK) for 30 min at room temperature.
Sections were then incubated with non-immune serum for 20 min. A mixture of
primary antibodies, including anti-RNAP II (Covance, Emeryville, CA, USA), anti-
cytokeratin 7 (DAKO, Ely, UK), anti-H3K4Me2 (Millipore, Consett, UK), and anti-
H3K4Me3 (Abcam, Cambridge, UK), was applied overnight at 4 C. The sections were
washed and incubated for 1 h at room temperature with species-speciﬁc Alexa-488
or Alexa-568 secondary ﬂuorescent antibodies (Molecular Probes, Invitrogen
Detection Technologies, Leiden, The Netherlands). Sections were washed in TBS and
ﬁnally in water, and subsequently mounted in Vectashield mounting medium
containing DAPI (Vector Laboratories, Peterborough, UK). Images were captured
using a Leica confocal microscope (LeicaTCS-NT, Leica Instruments GmbH,
Germany).
The above protocol was also followed for immunohistochemistry, with the
following exceptions. Endogenous peroxidase activity was blocked prior to primary
antibody treatment by incubation in 3% H2O2 for 15 min at room temperature.
Biotin-labelled secondary antibodies were used and binding was detected using
Vectastain Elite ABC kits (Vector Laboratories, Peterborough, UK) and SigmaFast DAB
(Sigma, Poole, UK), according to the manufacturers’ instructions. Sections were then
lightly counterstained with haematoxylin. Negative controls were performed by
replacement with an equal concentration of non-immune or isotype matched
irrelevant control.
2.3. Fluorouridine (FU) incorporation assay
The following protocol was developed from the work of Dimitrova and of
Boisvert et al. who applied the technique to assay transcription in cell culture work,
and from the methods of Watson et al. who studied incorporation of bromodeox-
yuridine (BrdU) into placental villi [9–11].
Villi from ﬁrst trimester and term placentas were placed immediately into
culture medium (TCS large vessel endothelial cell basal medium (TCS CellWorks,
Milton Keynes, UK), containing 2% fetal bovine serum, heparin, hydrocortisone,
human epidermal growth factor, human basic ﬁbroblast growth factor, 25 mg/ml
gentamicin and 50 ng/ml amphotericin B, 1 mM vitamin C and 1 mM Trolox) pre-
equilibrated with 2.5% O2/92.5% N2/5% CO2. FU was added to the experimental
samples to a ﬁnal concentration of 2 mM. Control samples were placed in medium
not containing FU. Samples were then incubated at 37 C for 1 h. For term placentas,
control samples were pre-treated with an RNAP II inhibitor, a-amanitin (40 mg/ml;
Sigma), for 30 min at 37 C, followed by incubation with 2 mM FU for a further 1 h.
Fixation andparafﬁn-embeddingwere carried out on all samples, as described above.
FU was detected immunohistochemically with an anti-BrdU mouse monoclonal
antibody (Sigma) which reacts with both BrdU and FU [10]. Immunohistochemistrywas carried out as described above, with several modiﬁcations. A 30 min incubation
with 2 M HCl at 37 C was performed prior to anti-BrdU treatment to cause DNA
denaturation. Instead of proteinase K, slides were incubated individually with
trypsin solution (Sigma) for 20 min at 37 C. Slides were not counterstained with
haematoxylin; instead, they were rinsed in dH2O and cover-slipped with a perma-
nent aqueous mount.
2.4. MTT assay
To conﬁrm syncytial viability, an MTT test was performed, as previously
described [11]. Ten to ﬁfteen milligram samples of placental villi were placed in
culture medium containing 0.5 mg/ml 3-(4,5-dimethyldiazol-2-yl)-2,5-diphenylte-
trazolium bromide (MTT), and incubated for 20 min at 37 C in the dark. Sections
were frozen in OCT (Tissue-Tek), then sectioned on a cryotome and mounted onto
microscope slides. Mitochondrial activity was demonstrated by the incorporation of
a blue formazan cleavage product.
2.5. Electron microscopy
Following secondary ﬁxation in 1% osmium tetroxide for 1 h, samples were
embedded in Araldite epoxy resin. Semi-thin sections (1 mm) were stained with
methylene blue, whereas ultra-thin sections (50 nm) were counterstained with
uranyl acetate followed by lead citrate and viewed using a Philips CM100
microscope.
3. Results
3.1. RNA polymerase II (RNAP II) immunoﬂuorescence
Immunoﬂuorescence staining for RNAP II and cytokeratin 7 was
carried out on villi from eight early pregnancy placentas, ranging
from 5 to 14 weeks in age, and at term (Fig. 1A–E). Cytokeratin 7
was used to identify trophoblast cell boundaries, and thus to
discriminate between the STB and CTB. Immunoreactivity for RNAP
II was seen in a proportion of the CTB, STB and stromal nuclei in all
the samples. The proportion of nuclei staining in these tissues
varied with gestational age. Early in the ﬁrst trimester, 5–8 weeks
(n¼ 4), the villous trophoblast was variable in its immunoreac-
tivity, with some regions almost devoid of RNAP II-positive nuclei,
and others abundant in them (Fig. 1A and B). Immunoreactivity of
the STB seemed to correlate with the presence of RNAP II in the
underlying CTB, but not vice versa. Stromal staining for RNAP II was
infrequent.
Later in the ﬁrst trimester and early second trimester (9–14
weeks, n¼ 4), RNAP II-immunoreactive nuclei were more abun-
dant, and were seen in the trophoblast and stroma of almost all villi
(Fig. 1C and D). A similar pattern was observed at term (n¼ 4)
(Fig. 1E). Autoﬂuorescence and non-speciﬁc binding of the
secondary antibody were negligible, as demonstrated by the lack of
staining in the negative controls (Fig. 1F).
On the subnuclear level, RNAP II was variable in quantity,
ranging from almost complete coverage of the nucleus to just small
clumps of staining. Even in the most densely staining nuclei, RNAP
II staining was seen to be absent from the central region of the
nucleus, presumed to be the nucleolus, providing evidence of
selectivity for this form of the polymerase.
3.2. FU incorporation assay
Villi from ﬁrst trimester placentas (n¼ 2) that were incubated
with FU and stained with an anti-BrdU antibody displayed wide-
spread immunoreactivity of trophoblast nuclei. Immunoreactivity
was seen in both CTB and STB nuclei, the latter being identiﬁed by
their proximity to the outer surface of the villus (Fig. 2A, arrows).
The staining intensity of the STB appeared to be greater than that of
the CTB in many cases. Control villi obtained from the same
placentas and incubated in the culture medium without FU dis-
played no evidence of immunoreactivity in the trophoblast or
Fig. 1. Detection of active RNAP II. (A–E) Immunoﬂuorescence for RNAP II (green), cytokeratin 7 (red) and DAPI (blue). Examples of RNAP II-immunoreactive STB nuclei are
illustrated by arrows. (F) Negative control (omission of primary antibodies). Gestational ages (weeksþ days) are given at the top right of the images. Scale bar¼ 20 mm for all images.
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protocol (Fig. 2D, E).
In term placentas (n¼ 3), the abundance of densely staining
nuclei was much lower and was conﬁned to the periphery of the
villi studied (Fig. 2B), but was still consistently observed, with
controls showing no immunoreactivity for FU (Fig. 2E). In villi
incubated with both a-amanitin and FU, staining was virtually
absent (Fig. 2C).Fig. 2. FU incorporation into placental tissue, detected by immunohistochemical staining. B
trimester (9þ 2 week) placenta; (B) term caesarean placenta; (C) term caesarean placenta
control placenta. STB viability was conﬁrmed by the presence of blue staining in an MTT test,
Scale bar¼ 25 mm for (A), and 50 mm for (B–F).3.3. MTT assay
Blue staining was seen in the trophoblast of both early preg-
nancy and term villi (Fig. 2F), demonstrating that mitochondrial
function was preserved during the incubation period. The cryostat
sections showed a thick trophoblast layer with no evident
detachment from the underlying stroma, suggesting that no
syncytial degeneration had occurred (Fig. 2F).rown staining on the light photomicrographs indicates the presence of FU, in: (A) ﬁrst
incubated with a-amanitin; (D) ﬁrst trimester control placenta. (E) Term caesarean
as shown in (F) for ﬁrst trimester placenta. Arrows indicate immunoreactive STB nuclei.
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Immunoﬂuorescent staining of ﬁrst trimester (n¼ 6) and term
(n¼ 4) placental villi for dimethylated lysine 4 on histone H3
(H3K4Me2) demonstrated widespread nuclear immunoreactivity
in both layers of the trophoblast and in the stroma (Fig. 3A and B).
Additionally, H3K4Me2 often co-localised with active RNAP II in the
trophoblast and stromal nuclei of all the ﬁrst trimester villi exam-
ined (n¼ 4) (Fig. 3D1–3). Some nuclei were observed to contain the
modiﬁed histone but not RNAP II, but not vice versa. Auto-
ﬂuorescence and non-speciﬁc binding were negligible, as demon-
strated by a lack of staining in the negative controls (not shown).
Immunohistochemistry was also performed on ﬁrst trimester
(n¼ 5) placental villi for dimethylated lysine 4 on histone H3
(H3K4Me3). Highly selective nuclear immunoreactivity was seen,
and was mainly localised to stromal and CTB cells, with little
involvement of the STB (Fig. 3C). A negative control showed non-
speciﬁc binding of the secondary antibody to be negligible (not
shown).
3.5. Electron microscopy
In the earliest gestational age samples examined the STB nuclei
displayed an open euchromatic appearance similar to that in the
CTB cells, with only occasional small aggregates of heterochromatin
at the margins or within the nuclear proﬁle. Nucleoli were
a prominent feature in nearly all these nuclei (Fig. 4A). As gestation
advanced into the second trimester heterochromatin became more
conspicuous, but still occupied only a relatively small percentage of
the nuclear proﬁles. Nucleoli were still seen, but less frequently
(Fig. 4B). These trends were more exaggerated at term, when dense
aggregates of heterochromatin were present in some STB nuclei,
and nucleoli were rare (data not shown).Fig. 3. Detection of modiﬁed histones. (A and B) Immunoﬂuorescence for H3K4Me2 (red) an
for H3K4Me3 (brown). Nuclei are counterstained with haematoxylin (blue). (D1–3) Immuno
weeks). Arrows indicate co-localisation of H3K4Me2 and RNAP II immunoreactivity in STB n
given at the top right of the images. Scale bar¼ 20 mm for (A), (B) and (D), and 10 mm for (4. Discussion
4.1. Evidence for STB transcription
The results of all three experimental approaches conﬁrmed that
active transcription occurs in a sub-set of the STB nuclei. Qualita-
tively, it appears that such nuclei are more frequent in early second
trimester tissue than at term, but further quantitative studies are
required to conﬁrm this impression.
RNAP II is the polymerase responsible for the synthesis of mRNA
(as opposed to rRNA or tRNA), and the antibodywe used to detect it
was speciﬁc to H5, a serine-phosphorylated form of the polymerase
only found in actively transcribing cells [12,13]. We can thus infer
that the observed immunoreactive STB cells are producing nascent
mRNA transcripts. The observation that RNAP II-positive STB nuclei
tend to cluster in regions where CTB immunoreactivity is also
observed may be indicative that the active STB nuclei are those that
have recently been incorporated into the tissue. This interpretation
is consistent with the euchromatic appearance of fully differenti-
ated CTB cells prior to fusion with the STB [14].
The FU incorporation assay provided further evidence that
transcription is occurring in both the trophoblast and stromal cells.
No immunoreactivity was seen in the negative controls where FU
was omitted, or following pre-treatment and incubation with
a-amanitin. This potent and selective RNAP II inhibitor blocks the
elongation of nascent transcripts [15,16], and has previously been
used successfully on placental explants [17]. The only ﬁnding from
the FU incorporation experiment inconsistent with the RNAP II
results was that STB nuclei were often more strongly immunore-
active than CTB or stromal cells. Themost likely explanation for this
effect was that there was insufﬁcient time during the incubation
period for the FU to diffuse towards nuclei deeper in the villous
core. The incubation period was kept short to ensure viability of thed DAPI (blue). Arrows indicate immunoreactive STB nuclei. (C) Immunohistochemistry
ﬂuorescence for H3K4Me2 (red), RNAP II (green) and DAPI (blue) (gestational age 9þ 3
uclei. Arrows indicate immunoreactive STB nuclei. Gestational ages (weeksþ days) are
C).
Fig. 4. Electron micrographs showing examples of euchromatic STB nuclei with prominent nucleoli. Gestational ages (weeks) are given at the top right of the images. Scale
bar¼ 2 mm.
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MTT assay.
Further information concerning the transcriptional status was
obtained by looking for the presence of histone modiﬁcations.
Histones are highly conserved, basic proteins that package the DNA
into chromatin and inﬂuence genome architecture and function.
They can undergo enzyme-catalysed covalent modiﬁcations, which
can affect their interactions with DNA, many leading to the
recruitment of further proteins with diverse consequences [19]. The
modiﬁcations we examined were di- and trimethylated H3K4
(H3K4Me2 and H3K4Me3, respectively) that are associated with
active euchromatic regions in mammalian cells, with H3K4Me3 in
particular being enriched at transcriptionally active promoters
[20–22]. Our results show both modiﬁcations to be present in
a proportion of villous trophoblast cells, and the observation that
a marker for active chromatin, H3K4Me2, co-localised with active
RNAP II in many STB nuclei provides further strong evidence that
transcription is taking place.
Despite this ﬁnding, the distribution of H3K4Me3 was less
extensive in the STB than might be expected from our RNAP II
results. An explanationmay be provided by the work of Kimura and
colleagues, who used chromatin immunoprecipitation to examine
histone modiﬁcations at the human growth hormone (hGH) gene
cluster in fusing primary CTBs isolated from human term placentas
[23,24]. Activation of these genes during fusion is associated with
robust acetylation of histones H3 and H4, but the lower quantity
and temporal pattern of H3 lysine 4 methylation suggest it plays
a role in ‘priming’ the genes for activation [24].
These data are consistent with ultrastructural observations of
the STB nuclei. The majority of the nuclei in the ﬁrst trimester, but
also a small proportion at term, display a prominent nucleolus,
consistent with previous observations [2]. The nucleolus is the site
of rRNA production [25], indicating that the STB has the capacity to
produce its own ribosomes rather than being passively replenished
when CTB cells fuse into the syncytium. It would be rather unusual
for a nucleus to be able to transcribe one type of RNA but not
another.4.2. Comparison with 3H-uridine labelling data
As mentioned earlier, previous in vitro experiments revealed
little or no incorporation of 3H-uridine into either ﬁrst trimester or
term STB nuclei [5,6]. This disparity with the current ﬁndings may
reﬂect the contrasting culture conditions employed. In the previous
studies villous explants were maintained for 1 h under 95% oxygen,
5% carbon dioxide at 2.5 atmosphere pressure, conditions which
are now recognised as being hyperoxic for placental tissues in vivo
[26]. Although viability of the STB was maintained throughout theculture period, it is possible that an as yet unidentiﬁed stress led to
the suppression of transcription under these conditions.4.3. Implications of STB transcription
The ability of the STB to produce its own mRNA transcripts is in
keeping with its highmetabolic and secretory activity. For example,
towards term the STB secretes approximately 1 g of placental
lactogen per day [27], and the transcripts encoding this hormone
account for approximately 10% of all placental transcripts. In situ
hybridization using tritiated probes has localised these transcripts
exclusively to the STB in ﬁrst trimester samples, with only a few
scattered grains overlying the CTB cells [28].
It will also permit the STB to adapt rapidly to changes in the
intrauterine environment without any delay caused by the addi-
tional need for CTB fusion. It was notable that on all the immuno-
ﬂuorescence slides examined, villi from 9 to 14 weeks gestation
displayed more widespread RNAP II immunoreactivity in all tissue
compartments than villi from 5 to 8 weeks. Furthermore, their
nuclei tended to display a greater density of RNAP II staining,
a variable associated with the number of nascent transcripts being
produced [29]. This difference may relate to the onset of the hae-
mochorial circulation to the placenta, when there is a threefold
increase in the oxygen concentration in the maternal intervillous
space. The change in transcriptional activitymay be associatedwith
the rise in mRNA transcripts encoding antioxidant enzymes in
villous tissue at that time [26], and/ormay reﬂect a general increase
in the metabolic activity of the tissue driven by the higher oxygen
availability.
Not all STB nuclei appear to be transcriptionally active, however,
indicating that some form of selective regulation does occur.
Quantitative data obtained using the disector technique reveal that
the number of STB nuclei increases exponentially until term,
increasing from 6.2109 at 13–15 weeks to 58.1109 at 37–39
weeks [30]. Whether only a proportion of these is needed to
produce sufﬁcient transcripts, given the syncytial nature of the
tissue, or whether nuclei that have sustained oxidative or some
other form of damage are preferentially inactivated is not known.
Alternatively, the different transcriptional states of these cells
may reﬂect distinct sub-populations with different properties.
Further quantitative studies are required to determine whether the
proportion of active nuclei remains constant across pregnancy and
in pathological conditions, for qualitative impressions based on
viewing sections are potentially misleading. Spatial dispersal of the
RNAP II-positive nuclei as the villous tree enlarges may create
a false impression as to their true frequency, as previously
demonstrated in the case of CTB cells [31].
The mechanism by which STB transcription is controlled is also
unclear. That there is heterogeneity in the chromatin pattern
P.M. Ellery et al. / Placenta 30 (2009) 329–334334amongst STB nuclei, and that the frequency of syncytial knots
increases towards term, are incontrovertible [3,32]. It has been
suggested that these changes represent progression along the
apoptotic pathway [8]. Indeed, it was proposed that activation of
the apoptotic cascade is a key event during CTB fusion, but that
once the nucleus is incorporated into the STB, progression is
delayed for several weeks due to high levels of Bcl-2 carried in from
the CTB cytoplasm [7]. Cytotrophoblast cells can, and do, undergo
apoptosis [14], but whether apoptosis is part of the fusion mecha-
nism has recently been questioned [33,34]. Nuclear blebbing and
fragmentation are not observed in syncytial knots; indeed Jones
and Fox commented on the very smooth contours of the nuclei,
permitting their close juxtaposition [32]. Another possibility is that
histone modiﬁcations, such as methylation, phosphorylation or
acetylation, may lead to repackaging and inactivation of the DNA,
and further work is required to explore this possibility.
In conclusion, we have provided direct and indirect evidence
that a proportion of nuclei in the syncytiotrophoblast of the human
placenta is actively engaged in producing RNA transcripts, both in
early pregnancy and at term. Future experimental work is seeking
to quantify the proportion of nuclei that are transcriptionally active,
and examine the molecular mechanisms by which activity is
regulated.
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